Join
Live feed
·
PRReleasevia Quantisnow
Aktis Oncology Inc. logo

Akoustis Reports Fourth Consecutive Quarter of Record Revenue as First Quarter Fiscal 2023 Sales Grew over 195% Year-Over-Year

ByQuantisnow·Wall Street's wire, on your screen.
AKTS· Aktis Oncology Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKTS (Aktis Oncology Inc.) and more on Quantisnow.